Incyte Corp.

NAS: INCY

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 25, 2020, 9:36 a.m.

/zigman2/quotes/204510994/composite

$

84.86

Change

-0.21 -0.25%

Volume

Volume 17,420

Real time quotes

/zigman2/quotes/204510994/composite

Previous close

$ 85.07

$ 84.86

Change

-0.21 -0.25%

Day low

Day high

$84.37

$85.22

Open

52 week low

52 week high

$62.48

$110.37

Open

Insider Actions for Incyte Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/11/2020 Maria E. Pasquale
EVP & General Counsel
127   Derivative/Non-derivative trans. at $65.36 per share. 8,300
09/10/2020 Maria E. Pasquale
EVP & General Counsel
2,193   Disposition at $90.83 per share. 199,190
09/10/2020 Maria E. Pasquale
EVP & General Counsel
2,193   Derivative/Non-derivative trans. at $65.36 per share. 143,334
09/08/2020 Dashyant Dhanak
EVP & Chief Scientific Officer
961   Disposition at $88.94 per share. 85,471
09/08/2020 Dashyant Dhanak
EVP & Chief Scientific Officer
961   Derivative/Non-derivative trans. at $65.42 per share. 62,868
08/27/2020 Wendy L. Dixon
Director
20,000   Disposition at $94.51 per share. 1,890,200
08/27/2020 Wendy L. Dixon
Director
20,000   Derivative/Non-derivative trans. at $18.97 per share. 379,400
08/10/2020 Maria E. Pasquale
EVP & General Counsel
128   Derivative/Non-derivative trans. at $65.36 per share. 8,366
08/06/2020 Dashyant Dhanak
EVP & Chief Scientific Officer
961   Disposition at $97.8 per share. 93,985
08/06/2020 Dashyant Dhanak
EVP & Chief Scientific Officer
961   Derivative/Non-derivative trans. at $65.42 per share. 62,868
07/16/2020 Steven H. Stein
EVP & Chief Medical Officer
766   Disposition at $103.83 per share. 79,533
07/15/2020 Hervé Hoppenot
Chairman / CEO; Director
2,420   Derivative/Non-derivative trans. at $104.25 per share. 252,285
07/15/2020 Steven H. Stein
EVP & Chief Medical Officer
623   Derivative/Non-derivative trans. at $104.25 per share. 64,947
07/15/2020 Paula J. Swain
EVP, Human Resources
626   Derivative/Non-derivative trans. at $104.25 per share. 65,260
07/15/2020 Barry P. Flannelly
EVP & General Manager US
639   Derivative/Non-derivative trans. at $104.25 per share. 66,615
07/15/2020 Paul Trower
Principal Accounting Officer
203   Derivative/Non-derivative trans. at $104.25 per share. 21,162
07/15/2020 Wenqing Yao
EVP, Head of Discovery Chem
639   Derivative/Non-derivative trans. at $104.25 per share. 66,615
07/13/2020 Dashyant Dhanak
EVP & Chief Scientific Officer
2,419   Derivative/Non-derivative trans. at $65.42 per share. 158,250
07/10/2020 Maria E. Pasquale
EVP & General Counsel
127   Derivative/Non-derivative trans. at $65.36 per share. 8,300

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
38 Purchases
45 Sales
400,267
343,513
Last 6 months
82 Purchases
66 Sales
584,928
435,889
Last 12 months
144 Purchases
103 Sales
965,069
702,511

Officers and Executives

Mr. Hervé Hoppenot
Chairman, President & Chief Executive Officer
Ms. Christiana Stamoulis
Chief Financial Officer & Executive Vice President
Dr. Steven H. Stein
Chief Medical Officer & Executive Vice President
Dr. Dashyant Dhanak
Chief Scientific Officer & Executive VP
Dr. Wenqing Yao
Executive Vice President-Discovery Chemistry
Dr. Robert Newton
Vice President-Drug Discovery Biology
Dr. Kim Solomon
Vice President-Project Management
Dr. Keith Mikkelson
Executive Director-Business Development
Dr. Barry P. Flannelly
Executive Vice President & General Manager
Dr. Holly Koblish
Associate Director
Dr. Phillip Liu
Associate Director-Applied Technology
Mr. Paul Trower
Vice President-Finance
Mr. Michael Morrissey
Executive VP & Head-Global Technical Operations
Dr. Vijay Iyengar
EVP-Global Strategy & Corporate Development
Dr. Lothar H. Finke
Head-Clinical Development & General Manager-Japan
Mr. Peter Langmuir
Vice President-Oncology Drug Development
Dr. Katherine A. High
Non-Executive Director
Dr. Michael Charles A. Booth
Vice President-Investor Relations
Ms. Paula J. Swain
Executive Vice President-Human Resources
Ms. Maria E. Pasquale
Secretary, Executive VP & General Counsel
Dr. Edmund P. Harrigan
Independent Director
Dr. Paul A. Friedman
Independent Director
Dr. Wendy L. Dixon
Independent Director
Mr. Jean-Jacques Bienaimé
Independent Director
Mr. Julian Charles Baker
Lead Independent Director
Link to MarketWatch's Slice.